advertisement
Liebmann JM 36
Showing records 1 to 25 | Display all abstracts from Liebmann JM75682 Baseline 24-2 Central Visual Field Damage Is Predictive of Global Progressive Field Loss
Garg A
American Journal of Ophthalmology 2018; 187: 92-98
75246 A Longitudinal Analysis of Peripapillary Choroidal Thinning in Healthy and Glaucoma Subjects
Mundae RS
American Journal of Ophthalmology 2018; 186: 89-95
75179 Relationship Between Optic Nerve Head Drusen Volume and Structural and Functional Optic Nerve Damage
Skaat A
Journal of Glaucoma 2017; 26: 1095-1100
75175 Hybrid Deep Learning on Single Wide-field Optical Coherence tomography Scans Accurately Classifies Glaucoma Suspects
Muhammad H
Journal of Glaucoma 2017; 26: 1086-1094
75428 Latanoprostene Bunod 0.024% in Subjects With Open-angle Glaucoma or Ocular Hypertension: Pooled Phase 3 Study Findings
Weinreb RN
Journal of Glaucoma 2018; 27: 7-15
75246 A Longitudinal Analysis of Peripapillary Choroidal Thinning in Healthy and Glaucoma Subjects
Zangwill LM
American Journal of Ophthalmology 2018; 186: 89-95
75175 Hybrid Deep Learning on Single Wide-field Optical Coherence tomography Scans Accurately Classifies Glaucoma Suspects
Fuchs TJ
Journal of Glaucoma 2017; 26: 1086-1094
75682 Baseline 24-2 Central Visual Field Damage Is Predictive of Global Progressive Field Loss
De Moraes CG
American Journal of Ophthalmology 2018; 187: 92-98
75428 Latanoprostene Bunod 0.024% in Subjects With Open-angle Glaucoma or Ocular Hypertension: Pooled Phase 3 Study Findings
Liebmann JM
Journal of Glaucoma 2018; 27: 7-15
75179 Relationship Between Optic Nerve Head Drusen Volume and Structural and Functional Optic Nerve Damage
Muylaert S
Journal of Glaucoma 2017; 26: 1095-1100
75682 Baseline 24-2 Central Visual Field Damage Is Predictive of Global Progressive Field Loss
Cioffi GA
American Journal of Ophthalmology 2018; 187: 92-98
75246 A Longitudinal Analysis of Peripapillary Choroidal Thinning in Healthy and Glaucoma Subjects
Kabbara SW
American Journal of Ophthalmology 2018; 186: 89-95
75428 Latanoprostene Bunod 0.024% in Subjects With Open-angle Glaucoma or Ocular Hypertension: Pooled Phase 3 Study Findings
Martin KR
Journal of Glaucoma 2018; 27: 7-15
75175 Hybrid Deep Learning on Single Wide-field Optical Coherence tomography Scans Accurately Classifies Glaucoma Suspects
De Cuir N
Journal of Glaucoma 2017; 26: 1086-1094
75179 Relationship Between Optic Nerve Head Drusen Volume and Structural and Functional Optic Nerve Damage
Mogil RS
Journal of Glaucoma 2017; 26: 1095-1100
75175 Hybrid Deep Learning on Single Wide-field Optical Coherence tomography Scans Accurately Classifies Glaucoma Suspects
De Moraes CG
Journal of Glaucoma 2017; 26: 1086-1094
75246 A Longitudinal Analysis of Peripapillary Choroidal Thinning in Healthy and Glaucoma Subjects
Hammel N
American Journal of Ophthalmology 2018; 186: 89-95
75682 Baseline 24-2 Central Visual Field Damage Is Predictive of Global Progressive Field Loss
Girkin CA
American Journal of Ophthalmology 2018; 187: 92-98
75179 Relationship Between Optic Nerve Head Drusen Volume and Structural and Functional Optic Nerve Damage
Furlanetto RL
Journal of Glaucoma 2017; 26: 1095-1100
75428 Latanoprostene Bunod 0.024% in Subjects With Open-angle Glaucoma or Ocular Hypertension: Pooled Phase 3 Study Findings
Kaufman PL
Journal of Glaucoma 2018; 27: 7-15
75175 Hybrid Deep Learning on Single Wide-field Optical Coherence tomography Scans Accurately Classifies Glaucoma Suspects
Blumberg DM
Journal of Glaucoma 2017; 26: 1086-1094
75428 Latanoprostene Bunod 0.024% in Subjects With Open-angle Glaucoma or Ocular Hypertension: Pooled Phase 3 Study Findings
Vittitow JL
Journal of Glaucoma 2018; 27: 7-15
75179 Relationship Between Optic Nerve Head Drusen Volume and Structural and Functional Optic Nerve Damage
Netto CF
Journal of Glaucoma 2017; 26: 1095-1100
75682 Baseline 24-2 Central Visual Field Damage Is Predictive of Global Progressive Field Loss
Medeiros FA
American Journal of Ophthalmology 2018; 187: 92-98
75246 A Longitudinal Analysis of Peripapillary Choroidal Thinning in Healthy and Glaucoma Subjects
Bowd C
American Journal of Ophthalmology 2018; 186: 89-95
